VAERS reports by lot

GSK DTaP/Tdap lot EB499: VAERS reports

27 VAERS reports list lot EB499 as a GSK DTaP/Tdap vaccine, received between 2025-04-21 and 2026-02-23. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1932%
Neurological915%
Musculoskeletal813%
General / Systemic (non-local)813%
Dermatological (non-injection-site)610%
Allergic / Anaphylactic47%
Cardiac / Cardiovascular35%
Psychiatric / Neuropsychiatric23%
Gastrointestinal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Tennessee4
Texas3
Oregon3
Ohio2
Georgia2
California2
North Carolina1
Connecticut1
Alabama1
Pennsylvania1
Michigan1
Arkansas1

Reports by month received

MonthReportsBar
2025-042
2025-056
2025-063
2025-079
2025-081
2025-091
2025-102
2025-111
2025-121
2026-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): DD7F7 · DR2GR · E2L54 · EC9A9 · ET475 · F5492

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.